DE602004009313D1 - Organosiliziumverbindungen und deren verwendung - Google Patents

Organosiliziumverbindungen und deren verwendung

Info

Publication number
DE602004009313D1
DE602004009313D1 DE602004009313T DE602004009313T DE602004009313D1 DE 602004009313 D1 DE602004009313 D1 DE 602004009313D1 DE 602004009313 T DE602004009313 T DE 602004009313T DE 602004009313 T DE602004009313 T DE 602004009313T DE 602004009313 D1 DE602004009313 D1 DE 602004009313D1
Authority
DE
Germany
Prior art keywords
organosilicate compounds
organosilicate
compounds
formula
variables
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004009313T
Other languages
English (en)
Other versions
DE602004009313T2 (de
Inventor
David John Miller
Graham Andrew Showell
Richard Conroy
Juergen Daiss
Reinhold Tacke
David Tebbe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Cambridge Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0316090A external-priority patent/GB0316090D0/en
Priority claimed from GB0402903A external-priority patent/GB0402903D0/en
Priority claimed from GB0411071A external-priority patent/GB0411071D0/en
Application filed by Takeda Cambridge Ltd filed Critical Takeda Cambridge Ltd
Publication of DE602004009313D1 publication Critical patent/DE602004009313D1/de
Application granted granted Critical
Publication of DE602004009313T2 publication Critical patent/DE602004009313T2/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
DE602004009313T 2003-07-09 2004-06-18 Organosiliziumverbindungen und deren verwendung Expired - Fee Related DE602004009313T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0316090 2003-07-09
GB0316090A GB0316090D0 (en) 2003-07-09 2003-07-09 Compounds and their use
GB0402903 2004-02-10
GB0402903A GB0402903D0 (en) 2004-02-10 2004-02-10 Compounds and their use
GB0411071A GB0411071D0 (en) 2004-05-18 2004-05-18 Compounds and their use
GB0411071 2004-05-18
PCT/GB2004/002622 WO2005005443A1 (en) 2003-07-09 2004-06-18 Organosilicon compounds and their use

Publications (2)

Publication Number Publication Date
DE602004009313D1 true DE602004009313D1 (de) 2007-11-15
DE602004009313T2 DE602004009313T2 (de) 2008-01-10

Family

ID=34068755

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004009313T Expired - Fee Related DE602004009313T2 (de) 2003-07-09 2004-06-18 Organosiliziumverbindungen und deren verwendung

Country Status (13)

Country Link
US (1) US20070111967A1 (de)
EP (1) EP1648906B1 (de)
JP (1) JP2007516192A (de)
KR (1) KR20060029282A (de)
AT (1) ATE374778T1 (de)
AU (1) AU2004255913B2 (de)
BR (1) BRPI0412360A (de)
CA (1) CA2531512A1 (de)
DE (1) DE602004009313T2 (de)
DK (1) DK1648906T3 (de)
ES (1) ES2293293T3 (de)
MX (1) MXPA06000371A (de)
WO (1) WO2005005443A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106535891A (zh) * 2014-06-02 2017-03-22 Chdi基金会股份有限公司 组蛋白脱乙酰酶抑制剂及其组合物和使用方法
AU2015308987B2 (en) 2014-08-26 2021-02-18 Betanien Hospital Methods, agents and compositions for treatment of inflammatory conditions
CA3093802A1 (en) 2018-03-13 2019-09-19 Shire Human Genetic Therapies, Inc. Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof
EP4031547A1 (de) 2019-09-18 2022-07-27 Takeda Pharmaceutical Company Limited Plasma-kallikreininhibitoren und verwendungen dafür
EP4031245A1 (de) 2019-09-18 2022-07-27 Takeda Pharmaceutical Company Limited Heteroaryl-plasma-kallikrein-inhibitoren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69924387D1 (de) * 1998-08-20 2005-04-28 Agouron Pharma Nicht-peptidische gnrh agentia, verfahren und zwischenverbindungen zur ihren herstellung
CA2489252A1 (en) * 2002-06-13 2003-12-24 Pfizer Inc. Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
EP1562611B1 (de) * 2002-11-20 2006-08-02 Paradigm Therapeutics Ltd. Heterozyklische siliziumverbindungen und deren verwendung zur behandlung von krankheiten oder zuständen, die mit gonadotropin-freisetzenden hormon assoziiert sind

Also Published As

Publication number Publication date
JP2007516192A (ja) 2007-06-21
MXPA06000371A (es) 2006-03-28
AU2004255913B2 (en) 2007-10-11
EP1648906A1 (de) 2006-04-26
KR20060029282A (ko) 2006-04-05
DE602004009313T2 (de) 2008-01-10
CA2531512A1 (en) 2005-01-20
AU2004255913A1 (en) 2005-01-20
ES2293293T3 (es) 2008-03-16
ATE374778T1 (de) 2007-10-15
EP1648906B1 (de) 2007-10-03
US20070111967A1 (en) 2007-05-17
BRPI0412360A (pt) 2006-09-05
DK1648906T3 (da) 2008-02-04
WO2005005443A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
CY1112780T1 (el) Νεα σουλφονυλοπυρρολια ως αναστολεις της ηdac
ATE471324T1 (de) Triazolophthalazine
MX2007005933A (es) Compuestos de acetamida como fungicidas.
CY1114284T1 (el) Σουλφονυλοπυρρολες ως hdac αναστολεις
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
MX2007005932A (es) 1-alquinil-2-ariloxialquilamidas y su uso como fungicidas.
TW200600499A (en) Novel amido-substituted hydroxy-6-phenylphenanthridines
CY1107156T1 (el) Νεα μεθοδος συνθεσης του (7-μεθοξυ-3,4-διυδρο-1-ναφθαλινυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγομελατινης
TW200700358A (en) Organic compounds
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
BRPI0512310A (pt) compostos quìmicos
DE50208918D1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
ATE353884T1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
ATE371662T1 (de) Siliziumverbindungen und deren verwendung
DE602004009313D1 (de) Organosiliziumverbindungen und deren verwendung
DE60215918D1 (de) Azofarbstoffe
BR0206922A (pt) Compostos orgânicos
ATE508130T1 (de) 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
DE602004002464D1 (de) IMIDAZOi4,5-BöCHINOLINDERIVATE UND IHRE VERWENDUNG ALS INHIBITOREN DER INDUZIERBAREN NO-SYNTHASE
ATE364037T1 (de) Tryptasehemmer
ATE273302T1 (de) Diazocinderivate und deren verwendung als tryptase inhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP

8339 Ceased/non-payment of the annual fee